Life Sciences

TechVision's Medical Devices and Imaging technology cluster's latest research service profiles ten technologies that are expected to have a huge impact on the healthcare industry in the next two years. This report provides an overview of the ten technologies, and provides key pointers that are needed for strategic decision-making. Each of these tec...

This strategic research service, Health & Wellness Top 10 Technologies, depicts the current landscape and the new trends in a series of developments associated with innovations in biosimilars, cancer screening, molecular scissors, next generation stem cells, three-dimensional (3D) scaffolds, therapeutic antibodies, cancer immunotherapy, high throug...

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across emerging cancer immunotherapies in the United States, from personalized cancer vaccines to novel targeted therapies. The corresponding patent scenario is depicted, along with the industry interactions. The Genetic Technology TechVision...

This edition of Medical Device Alert depicts trends across smart-cutaneous wearables, with advancements in health monitoring. The patent scenario for each technology profiled is also depicted. The Medical Device Alert analyses and reports on new and emerging technologies and advances in R&D; product development; and regulatory matters related to n...

This edition of Drug Discovery Alert depicts life sciences trends across novel drug delivery systems (NDDS). The physiochemical properties of some powerful novel therapeutics such as poor solubility and poor permeation can at times leads to mistargeting at the active site. This concern generates a barrier for therapeutic efficacy. Various nanoformu...

This edition of the Genetic Alert depicts the current landscape and the new life sciences trends across proteomic and molecular diagnostic technologies. The corresponding patent scenario is depicted, along with the industry interactions. The Genetic Alert presents the latest R&D developments and advances with an emphasis on opportunities to profit...

This Vital Signs issues discusses generic drug pricing, CRISPR technology, GenomeAsia 100K and large-scale next-generation sequencing projects, and Medicare outcomes target.

This research service covers key technological trends and developments in proteomic technologies that are likely to have a high impact in the near future. Based on the survey and observation of the global proteomics industry, advances and technological trends across existing and emerging proteomic technologies have been detailed. While providing br...

Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...